Effectiveness of artificial pancreas in perioperative glycemic control

Time course change of the insulin requirements during the perioperative period in hepatectomy and pancreatectomy by using an artificial pancreas STG-55. - Time course change of the insulin requirements during the perioperative period in hepatectomy and pancreatectomy by using an artificial pancreas STG-55.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000048616

Enrollment

Registered

2022-08-07

Start date

2019-02-25

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes mellitus, Hepatocellular carcinoma, Pancreatic cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who underwent hepatectomy or pancreatectomy using an artificial pancreas at the Department of Surgery,Okayama saiseikai hospital between February 2016 and April 2020.

Exclusion criteria

Exclusion criteria: (1) Patients who the researcher deems unsuitable as a research subject. (2) Patients who have been offered to not participate in this study.

Design outcomes

Primary

Measure	Time frame
1)Clinical findings (age, gender, height, weight, medical history, medicine, bleeding volume, pringle time, surgical time, length of hospital stay) 2) Blood findings (blood glucose level, HbA1c, C-peptide) 3) Artificial pancreas (IA value, IB value, insulin injection rate, glucose injection rate, total insulin dose, blood glucose level)	—

Countries

Japan

Contacts

Public ContactSanae Teshigawara

Okayama Saiseikai General Hospital Internal Medicine / Diabetes Center

sanaea@nifty.com086-252-2211

Outcome results